Medina AS, Motola KM, González HA, Herrera BH, González CO

Language: Spanish
References: 13
Page: 141-143
PDF size: 33.04 Kb.

ABSTRACT

Carcinoid tumors are rare entities, but are the most common neuroendocrine tumors in the gastrointestinal tract. Most of these tumors are found in the small intestine (45%), generally in the ileon, rectum (20%), appendix (16%), colon (11%), and the least common site is the stomach. The main treatment of these tumors is surgical intervention. The management of gastric carcinoids depends on the type; 1, 2 or 3. Type 3 or sporadic tumors are treated with partial or total gastrectomy with local lymph node resection. Medical treatment with an acidifying diet or with somatostatin analogs is still on debate and is restricted to patients in whom surgical treatment is a contraindication. This is a case report of a 63 year old man with a gastric carcinoid tumor. We discuss the existent bibliography related to this rare entity.

REFERENCES

1. Modlin IM, Lye KD, Kidd M. A 50-year analysis of 562 gastric carcinoids: Small tumor or larger problem? Am J Gastroenterol 2004; 99: 23.

2. Caplin ME, Buscombe JR, Hilson AJ, et al. Carcinoid tumour. Lancet 1998; 352: 799.

3. Capella C, Heitz PU, Hofler H, et al. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 1995; 425: 547.

4. Borch K, et al. Gastric carcinoids. Biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg 2005; 242: 64.

5. Hirschowitz BI, Griffith J, Pellegrin D, Cummings OW. Rapid regression of enterochromaffin like cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology 1992; 102: 1409.

6. Higham AD, Bishop LA, Dimaline R, et al. Mutations of Regl alpha are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia. Gastroenterology 1999; 116: 1310.

7. Dakin GF, Warner RR, Pomp A, et al. Presentation, treatment and outcome of type 1 gastric carcinoid tumors. J Surg Oncol 2006; 93: 368.

8. Soga J. Early-stage carcinoids of the gastrointestinal tract. Cancer 2005; 103:1587.

9. Gilligan CJ, Lawton GP, Tang LH, et al. Gastric carcinoid tumors: The biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol 1995; 90: 338.

10. Rindi G, Azzoni C, La Rosa S, et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: Prognostic evaluation by pathologic analysis. Gastroenterology 1999; 116: 532.

11. Landry CS, Woodall C, Scoggins CR, et al. Analysis of 900 appendiceal carcinoid tumors for a proposed predictive staging system. Arch Surg 2008; 143: 664.

12. Schindl M, Kaserer K, Niederle B. Treatment of gastric neuroendocrine tumors: The necessity of a type-adapted treatment. Arch Surg 2001; 136: 49.

13. Granberg D, Wilander E, Stridsberg M, et al. Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids. Gut 1998; 43: 223.